RJA
CBST

Raymond James & Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Raymond James & Associates’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,970
Closed -$2.01M – 2459
2014
Q4 		$2.01M Buy
19,970
+3,438
+21% +$267K 0.01% 1154
2014
Q3 		$1.1M Buy
16,532
+1,611
+11% +$106K 0.01% 1443
2014
Q2 		$1.04M Sell
14,921
-6,058
-29% -$412K 0.01% 1469
2014
Q1 		$1.53M Sell
20,979
-1,893
-8% -$141K 0.01% 1182
2013
Q4 		$1.57M Sell
22,872
-410
-2% -$26.5K 0.01% 1079
2013
Q3 		$1.48M Sell
23,282
-7,487
-24% -$453K 0.01% 1029
2013
Q2 		$1.49M Buy
+30,769
New +$1.51M 0.01% 965

Raymond James & Associates's CBST Position: Q1 2015 in Review

Raymond James & Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 19,970 shares — an estimated $2.01M sold.

Raymond James & Associates first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $2.01M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Raymond James & Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Raymond James & Associates sold 19,970 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $2.01M.
  • Raymond James & Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Raymond James & Associates's CUBIST PHARMACEUTICALS INC position peaked at $2.01M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Raymond James & Associates's 13F filing for Q1 2015, filed 28 Apr 2015.